Insider Watch: 3 CEOs Betting Millions on Their Own Stocks

Intel INTC CEO Lip-Bu Tan recently made a big splash, purchasing nearly $10 million worth of shares as part of the chipmaker’s recent stock offering. While this wasn’t a traditional open-market insider purchase, it still reflects a voluntary investment of the CEO’s own capital, signaling a strong vote of confidence as the company continues to execute a major turnaround.

Intel Benefits From AI-Driven Demand

Intel recently reported revenues of $16.1 billion, growing by a rock-solid 25% YoY and reflecting the highest growth rate we’ve seen from the company in more than a decade.

Importantly, its Data Center and AI business unit saw revenue surge nearly 60% YoY to $6.3 billion, with Intel Foundry also seeing 31% YoY revenue growth to $5.8 billion. These results show Intel benefiting from the AI infrastructure boom on multiple fronts, including surging demand for its data-center CPUs and growing activity within its manufacturing business.

The company’s earnings picture has strengthened in a big way over recent months, with EPS revisions remaining on a bullish trajectory.

Other Recent CEO Purchases

Intel isn’t alone in seeing its CEO step up with capital, as Pfizer PFE and CoStar Group CSGP have similarly seen their high-ranking executive make splashes as of late.

CoStar Group founder and CEO Andrew Florance recently purchased 83.3k shares at an average price of roughly $29.89 per share near the beginning of August. The purchase totaled roughly $2.5 million, with the CEO now holding more than 1.8 million shares in total.

Pfizer CEO Albert Bourla similarly put capital at play, purchasing 38k shares at roughly $26.34 per share. The transaction totaled just over $1 million, with the Pfizer CEO now holding more than 429k shares.

Bottom Line

Many investors closely monitor insider buys, seeking insights into the future. The purchases are often an overall huge positive concerning the longer-term outlook.

All stocks above – Intel INTC, CoStar Group CSGP, and Pfizer PFE  – have seen recent insider activity from their CEOs.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research